孕期孕产妇在父亲暴露于甲状腺素后的妊娠结果:系统性审查和元分析
Nusret Uysal1, Hüseyin Yilmaz2, Mesut Gungor2
1Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul, Turkey.
Birth defects research
|November 14, 2025
概括
在受孕前,父亲对甲状腺素 (MTX) 的暴露不会增加重大先天性形,死胎或早产的风险. 这一系统性审查为使用MTX的男性怀孕的胎儿安全提供了保证.
科学领域:
- 生殖毒理学 生殖毒理学
- 产周医学 产周医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有限的证据存在关于怀孕的安全性由男性暴露于甲状腺素 (MTX).
- 在受孕前或在受孕时,父亲对MTX的暴露可能对胎儿发育构成风险.
- 评估这些风险对于生殖咨询和管理至关重要.
研究的目的:
- 系统地审查和元分析父亲MTX暴露与不良妊娠结果之间的关联.
- 为了评估父亲MTX暴露后出现重大先天性形,死胎和早产的风险.
- 提供基于证据的指导,用于管理暴露于MTX.男性的怀孕.
主要方法:
- 在PubMed,Web of Science和Reprotox数据库中的系统文献搜索.
- 包括与未暴露的对照组进行的队列和病例控制研究;排除病例报告和综述.
- 对初级结果进行调整的几率比率的元分析;对数据不足进行叙事综合.
主要成果:
- 没有统计学意义上的重大先天性形风险增加 (aOR 1.00;95% CI 0.62-1.61).
- 没有观察到死产 (OR 0.85;95% CI 0.11-6.45) 或早产 (OR 0.95;95% CI 0.59-1.53) 的风险增加.
- 定性审查发现,在病例报告或病例系列中没有出现一致的发育不良模式.
结论:
- 在受孕前或在受孕时,父亲对MTX的暴露与先天性形,死胎或早产风险的增加无关.
- 研究结果表明,在父亲暴露于MTX后,对这些结果的胎儿安全性.
- 为临床医生和患者提供关于父亲MTX暴露和怀孕结果的保证.
更多相关视频
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
10.1K
05:55Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
Published on: June 17, 2025
741
相关概念视频
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Spermatogenesis
121.5K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
121.5K
